FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/09/015821 [Registered on: 24/09/2018] Trial Registered Retrospectively
Last Modified On: 28/03/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A Clinical trail to study the effect of classical Ayurvedic treatment in patients of Rheumatoid Arthritis. 
Scientific Title of Study   Evaluation of the effect of classical Ayurvedic treatment in the functional improvement of patients with Rheumatoid Arthritis 
Trial Acronym  ECAFR 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr E T Neelakandan Mooss 
Designation  Principal Investigator 
Affiliation  Vaidyaratnam Ayurveda Foundation 
Address  room no :107,Vaidyaratnam Ayurveda Foundation,vaidyaratnam Road Thaikkattussery Ollur

Thrissur
KERALA
680306
India 
Phone  9447025338  
Fax  04872355898  
Email  vaf2007@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sudarshan Nair P K  
Designation  Chief Research Coordinator 
Affiliation  Vaidyaratnam Ayurveda foundation 
Address  Room No:109,Vaidyaratnam Ayurveda Foundation, Thaikkattussery Ollur

Thrissur
KERALA
680306
India 
Phone  9446237396  
Fax  04872355898  
Email  nairsudarsan21@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sudeesh Kumar S 
Designation  Deputy Medical Superintendent 
Affiliation  Vaidyaratnam Ayurveda foundation 
Address  Room no:108,Vaidyaratnam Ayurveda Foundation, Thaikkattussery Ollur

Thrissur
KERALA
680306
India 
Phone  9497317627  
Fax  04872355898  
Email  ayur_sudi@yahoo.com  
 
Source of Monetary or Material Support  
Ministry of AYUSH, Governament of India,NewDelhi 
 
Primary Sponsor  
Name  Ministry of AYUSH Government of India 
Address  Ministry of AYUSH AYUSH Bhawan B BLOCK GPO Complex, INA New Delhi- 110023 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
Vaidyaratnam Ayurveda Foundation  Thaikkattussery, Ollur, Thrissur 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR E T NEELAKANDAN MOOSS  Vaidyaratnam Ayurveda Foundation   room no 107,Vaidyaratnam Ayurveda Foundation Centre of Excellence in Ayurvedic Management of Chronic Joint Disorder, Vaidyaratnam road, THAIKKATTUSSERY,OLLUR, THRISSUR, KERALA
Thrissur
KERALA 
9447025338
04872355898
vaf2007@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
institutional Ethical Committee  Approved 
vaidyaratnamCOEethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Rheumatoid Arthritis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  AMRITHOTHARAM KWATHAM,VAISHVANARAM CHOORNAM,RASNASAPTHAKAM KWATHAM,VYOSHADI GULGULU CHOORNAM,KOTTAMCHUKKADI THAILA,BALAGULOOCHYADI THAILA, CHOORNAPINDA SWEDA, PATRA POTTALI SWEDA  1ST 7DAYS INTERNALLY: 100ML AMRITHOTHARAM KWATHAM with 5gm VAISHVANARAM CHOORNAM at 6am and 6pm, EXTERNALLY CHOORNAP PINDA SWEDA with 800GM Shyamaka powder for forty five minutes, next 14 days INTERNALLY: 100ml RASNASAPTHAKAM KWATHAM with 1.5gm VYOSHADI GULGULU CHOORNAM 6am and 6pm, EXTERNALLY PATRA POTTALI SWEDA with 100MLkottamchukkadi thaila for forty five min, 5ml Balaguloochyadi thaila over head every day evening at 5pm  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patient with either sex with age between 20 to 60 years
2. Presence of any four out of the following seven criteria ( According to 2010, Revised criteria of American college of Rheumatology)
a) Morning stiffness lasting more than 6 weeks
b)Arthritis of three or more joints
c) Arthritis of hands
d) Presence of Rheumatoid nodules
e) Symmetric Arthritis
f) Serum Rheumatoid Arthritis/ ACCP positive
g) Abnormal CRP/ESR
3. Patient willing to participate in the study for 57days 
 
ExclusionCriteria 
Details  1. Patients who developed complications of Rheumatoid Arthritis
2. Patients who are unable to walk without support/ bedridden
3. Patients with poorly controlled Hypertension/ Diabetes/ Cardiac failure/ Hepatic disorder
4. Patients who are diagnosed with other arthritis
5. Alcoholics/ Pregnant woman/ Lactating Woman/ Hypersensitivity to drugs/ Prolonged medications 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Evaluation of the effect of classical Ayurvedic treatment in the functional improvement of patients with Rheumatoid Arthritis  1st, 7th,21st,42nd AND 57th day 
 
Secondary Outcome  
Outcome  TimePoints 
To establish the safety of ayurvedic line of management in Rheumatoid Arthritis  One and half year 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "50"
Final Enrollment numbers achieved (India)="50" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/05/2014 
Date of Study Completion (India) 22/11/2015 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 22/11/2015 
Estimated Duration of Trial   Years="1"
Months="6"
Days="15" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Yet to be published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
The study is a open clinical  trail conducted in Vaidyaratnam Ayurveda foundation, Thrissur, to evaluate the safety and efficacy of Ayurvedic management in Rheumatoid Arthritis ( Amavatam). The trail period  is 57days which includes 21 days of IP Treatments and 21 days of OP Treatments followed by 15 days of follow up period.  The target is 50 cases. The parameters for assessment includes Objective observations, subjective details, SF (36),  DAS 28 Score for  will be evaluated statistically. 






 
Close